SGLT2 Inhibitors: A New Era in Diabetes Therapy

adicionou um novo artigo Outro

2025-10-26 08:18:07

Sodium-glucose co-transporter 2 (SGLT2) inhibitors constitute an innovative pharmaceutical class that has fundamentally transformed treatment approaches for type 2 diabetes and associated health conditions. These cutting-edge medications function by inhibiting glucose reabsorption in the renal system, enabling excess sugar elimination through urinary excretion, thus achieving natural glycemic...

0 Comentários 0 Compartilhamentos 327 Visualizações 0 Anterior